This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Processo Tecnologico Da Amyris (Graphic: Business Wire)

Total (CAC: TOTF.PA) and Amyris, Inc. (NASDAQ: AMRS) announced today the signing of agreements to expand their current R&D partnership and form a joint venture to develop, produce and commercialize a range of renewable fuels and products.

Total and Amyris have agreed to expand their ongoing research and development collaboration to accelerate the deployment of Biofene ® and develop renewable diesel based on this molecule produced from plant sugars. The ambitious R&D program, launched in 2010 and managed jointly by researchers from both companies, aims to develop the necessary stages to bring the next generation renewable fuels to market at commercial scale. Total has committed to contribute $105 million in funding for an existing $180 million program.

In addition, Total and Amyris have agreed to form a 50-50 joint venture company that will have exclusive rights to produce and market renewable diesel and jet fuel worldwide, as well as non-exclusive rights to other renewable products such as drilling fluids, solvents, polymers and specific biolubricants. The venture aims to begin operations in the first quarter of 2012.

The creation of the joint venture and the implementation of the new renewable diesel R&D program are two more major steps forward for Total, which is aiming to become a key supplier in renewable fuels,” commented Philippe Boisseau, President of Gas & Power at Total. “ Renewable fuels produced with Amyris’s advanced technology will benefit from the know-how and customer access of Total, which operates in more than 130 countries. It will strengthen Total’s position in the global renewable diesel market, which is projected to nearly double in size to 32 million tons in 2020 from 17 million tons in 2010.

From fuels to chemicals and beyond, Amyris is working to usher in a new era when customers and consumers no longer have to compromise on traditional measures of value and performance when choosing a renewable alternative to petroleum-based products,” said John Melo, President & CEO of Amyris. “ With this expanded relationship and Total’s vast distribution network, as well as Total’s stated commitment to invest in production units, we expect to be able to co-develop products and, ultimately, deliver a global supply of sustainable renewable fuels at commercial scale. This is an ambitious undertaking ideally suited for our two companies.

About the Technology

Amyris has developed advanced microbial engineering and screening technologies that modify the way microorganisms process sugars. Amyris is using this industrial synthetic biology platform to design microbes, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable chemical and transportation fuel products.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,089.62 +65.56 0.36%
S&P 500 2,117.88 +9.59 0.45%
NASDAQ 5,032.9770 +27.5860 0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs